2009 Nobel Prize in Physiology or Medicine: Blackburn, Greider, and Szostak Discover the Clock at the End of Chromosomes

What You Will Learn in This Article

The 2009 Nobel Prize in Physiology or Medicine was awarded to three scientists who discovered telomeres, the specialized structures that protect the ends of chromosomes, and telomerase, the enzyme that lengthens them. Elizabeth Blackburn, an Australian scientist from UCSF, identified the repetitive sequences of telomeres in the Tetrahymena protozoan in the 1970s. Her graduate student, Carol Greider, discovered the telomerase enzyme in 1984. Jack Szostak, a Canadian scientist from Harvard, collaborated with Blackburn and demonstrated in yeast experiments that telomeres are essential for chromosome stability. These discoveries provided the first molecular-level answers to the questions: Why do cells have a limited number of divisions? Why do cancer cells bypass this limit? And why do we age? Today, these discoveries are the theoretical roots of research in cancer treatment, regenerative medicine, and aging.

Something Different from Common Knowledge: Cells Do Not Divide Infinitely

Until the 1960s, it was commonly believed that "cells could divide infinitely if provided with sufficient nutrients." The first to challenge this belief was American pathologist Leonard Hayflick. In 1961, he reported that normal human fibroblasts cultured in vitro would stop growing after approximately 50 to 60 divisions. This observation, later known as the Hayflick limit, suggested that cells have some kind of internal clock, but the nature of this clock remained a mystery for 30 years.

Blackburn, Greider, and Szostak identified the specific mechanism of this clock. The ends of chromosomes (telomeres) consist of thousands of repetitions of a 6-nucleotide sequence, TTAGGG, and this repetitive sequence shortens slightly with each cell division. This shortening is due to the physical limitations of the DNA replication system. DNA polymerase cannot completely replicate the ends of linear DNA, resulting in a small amount of information loss with each replication. This loss is absorbed by the telomeres. When telomeres shorten below a critical threshold, cells enter a state of senescence or undergo apoptosis.

If we express this in a CS framework, telomeres are a write-limit counter. Cells decrease this counter with each division, and when it falls below a critical value, execution is stopped. The subroutine that initializes this counter is telomerase. In normal somatic cells, this initialization is deactivated, resulting in a finite number of divisions. However, in germ cells, hematopoietic stem cells, and a small number of regenerative cells, telomerase is active, maintaining the counter. Cancer cells reactivate this telomerase, allowing them to enter a state of indefinite division.

The Context of the Times: A Year When Two Presidents Passed Away

2009 was a year of sorrow for South Korea. Former President Roh Moo-hyun died on May 23rd in Bongha Village. When the news broke that he had jumped from Owl Rock, the entire society was shocked, and mourners gathered at Seoul Plaza, Bongha Village, and memorial halls across the country for weeks. The prosecution's investigation and political pressure, as well as the social interpretations of his final decision, were the major topics of discussion in the first half of the year. Former President Kim Dae-jung passed away on August 18th. The only Nobel Peace Prize laureate in Korean history, the first leader to hold a North-South summit, and a symbol of democratization, his death marked a significant loss. The fact that both presidents passed away in the same year was a major event in political history.

In the political arena, debates intensified over the commencement of the Four Major River Restoration Project and the revision of the Sejong City plan. The Lee Myung-bak administration's large-scale national projects became the center of social conflict, with demonstrations and academic discussions taking place both inside and outside the National Assembly.

Globally, President Obama took office on January 20th, facing the task of recovering from the 2008 financial crisis. Each country implemented large-scale economic stimulus packages, but the real economy remained in a recession. The H1N1 influenza pandemic, which began in Mexico in April, spread around the world, becoming the first pandemic of the 21st century. Fortunately, the mortality rate was lower than expected, and a vaccine was developed relatively quickly, but the event revealed several vulnerabilities in the international infectious disease response system.

In the cultural sphere, Michael Jackson's death on June 25th marked the end of a 20th-century pop icon. James Cameron's "Avatar" was released in December, ushering in the era of commercial success for 3D movies. And a quiet beginning also took place: on January 3rd, Satoshi Nakamoto, an anonymous individual, mined the genesis block of Bitcoin. This event, which would later usher in the era of cryptocurrency, was at the time a minor experiment known only to some participants in an online forum.

In the scientific community, this award held special significance. It was the first time that two women had jointly received the Nobel Prize in Physiology or Medicine. Blackburn and Greider – a professor and a graduate student – receiving the award together was a symbolic moment in the progress of female scientists in the late 20th century and the increasing recognition of their contributions.

The Story of the Three Scientists: Three Labs, Starting with the Repetitive Sequences of a Protozoan

Elizabeth Blackburn (1948–) was born in Tasmania, Australia. She received her bachelor's and master's degrees from the University of Melbourne and her Ph.D. from Cambridge, working in the lab of Frederick Sanger (Nobel Prize for protein sequencing). Familiar with the early methods of DNA sequencing, she later joined Yale for postdoctoral research and became fascinated by Tetrahymena thermophila, a freshwater protozoan. The remarkable feature of this protozoan is that it has thousands of miniature chromosomes inside its macronucleus, and these chromosomes can be isolated in large quantities and their sequences read.

In 1978, Blackburn discovered the CCCCAA/GGGGTT repetitive sequence at the ends of Tetrahymena chromosomes. Her first telomere paper described that this sequence repeated multiple times on each chromosome, and that the number of repeats varied depending on the cell's state. Later, the repetitive sequence in humans and other vertebrates was established as TTAGGG. Blackburn soon became a professor at UCSF and grew into a leading figure in cell biology and chromosome research.

Jack Szostak (1952–) was born in Montreal, Canada. He studied at McGill University and Cornell University, and established his own laboratory at Harvard Medical School. His interest was in yeast genetics. Blackburn and Szostak met at a conference in 1980 and discussed the idea of collaborating: What would happen if the Tetrahymena telomere sequence was attached to an artificial linear chromosome in yeast? The results were surprising. The artificial chromosome with the telomere sequence was stably maintained, while the one without it was rapidly degraded. This result became the decisive experiment that proved the role of telomeres in chromosome stabilization. Szostak later developed the artificial yeast chromosome (YAC), which became a tool for the Human Genome Project, and also became known for his research on the early chemical origins of life.

Carol Greider (1961–) was born in San Diego, California. She received her bachelor's degree from UC Santa Barbara and joined Blackburn's graduate program at UC Berkeley. The problem she was assigned was: "How are telomeres maintained?" It was observed that telomeres, which should shorten with each round of DNA replication due to the physical limitations of the replication process, were maintained at a constant length in some cells, suggesting that there was an enzyme responsible for this.

Around Christmas 1984, Greider observed that when she added telomeric sequences to cell extracts from Tetrahymena and added radioactive labeled nucleotides, the sequence was extended. This was the first detection of telomerase activity. In the following years, the identity of this enzyme was revealed, and it turned out to be a ribonucleoprotein complex consisting of RNA and protein. The enzyme itself contains an RNA template, which is used to continuously add the telomeric repeat sequence to the end of the DNA. This discovery revealed that telomerase is a special reverse transcriptase – an enzyme related evolutionarily to the reverse transcriptase that appeared earlier in HIV. Greider later became a professor at Johns Hopkins University and led her own laboratory.

In one sentence, the discovery of the three scientists can be summarized as follows: Chromosome ends are protected by repetitive sequences, these sequences shorten with each division, and a special enzyme can re-extend them. These three observations redefined the molecular basis of cellular senescence and cancer.

Key Achievements: The Write-Limit Counter in the CS Framework

If we represent the cell's ability to divide as a pipeline, it would look like this:

• Initial State: A newly born cell has telomeres of a certain length (approximately 10 kb in humans). This is the initial counter value.
• Decreased with Each Division: During a cell division, DNA replication occurs, and the telomeres at the end of each chromosome shorten by approximately 50 to 100 base pairs. Counter -1.
• Critical Value Monitoring: When telomeres shorten below a certain critical value, the cell detects this as a DNA damage signal. Assertion systems such as p53 recognize this signal and stop the cell cycle or induce apoptosis. The result is replicative senescence or apoptosis.
• Counter Initialization Subroutine: Only in cells with active telomerase is the counter recharged. This subroutine is active in germ cells, hematopoietic stem cells, and a small number of regenerative tissues, allowing these cells to divide many more times.

The nature of this system is a resource management architecture that absorbs information loss in a controlled buffer zone. The physical limitations of DNA replication are unavoidable system constraints, but by using telomeres, a non-coding buffer sequence, the system protects against the loss of genetic information. The telomerase initialization subroutine is activated only in cells where it is needed, recharging this buffer zone.

The specificity of cancer cells can be newly understood from the perspective of this system. In most human cancers (approximately 90%), telomerase is reactivated. This is one of the necessary conditions for cancer cells to acquire the ability to divide indefinitely. Even if assertion systems such as p53 and Rb are inactivated, and cell cycle control is lost, if telomerase is not present, the cells will stop dividing after a few dozen divisions due to telomere crisis. Telomerase reactivation breaks this final barrier, and this reactivation is indeed known to be one of the critical gates in tumor progression.

However, the limitations of this analogy must also be made clear. Telomere length is not the only clock for cell and organism aging. There are many other factors that contribute to aging, including the accumulation of DNA damage, oxidative stress, mitochondrial dysfunction, epigenetic changes, and the breakdown of protein homeostasis, and these factors are interconnected. Telomeres are one of the important factors, but not the only one, and the simple equation that "increasing telomeres will lead to longer life" does not hold true. In fact, mice with artificially activated telomerase sometimes show delayed aging phenotypes, but also have an increased incidence of cancer. The balance of the entire system is crucial.

Why It Matters: Cancer, Regeneration, and Individual Aging Observations

First, it established a new axis in understanding cancer. Telomerase inhibitors have long been a goal in the development of anticancer drugs, and several compounds have undergone clinical trials in this direction. Since normal cells have low telomerase activity, these inhibitors theoretically have the appeal of being highly cancer-specific. Although actual clinical results are still limited, research in this area continues.

Second, it is the theoretical root of regenerative medicine. In the process of creating induced pluripotent stem cells (iPS cells), the Yamanaka factors bring about several initializations in the cells, one of which is telomerase reactivation. iPS cells are derived from adult cells, but they lengthen the telomeres again, restoring their ability to divide indefinitely. The cellular resources for regenerative medicine are being created based on telomere management. The 2012 Nobel Prize (Gurdon and Yamanaka) continues this line of research.

Third, telomere length measurement has been used in various studies since the 20th century as a marker of individual aging. Correlations have been reported in several epidemiological studies that psychological stress, sleep deprivation, obesity, and smoking accelerate telomere shortening, while regular exercise and good eating habits slow it down. However, there is still debate about the direction of cause and effect, and it is not yet reliable to predict human lifespan with a single indicator. Nevertheless, telomeres are one of the few quantitative indicators that can be used to observe cellular biological aging.

Fourth, it is related to genetic diseases. It has been revealed that congenital dyskeratosis, aplastic anemia, and certain pulmonary fibrosis are associated with mutations in telomerase-related genes. These patients experience symptoms of premature aging, decreased bone marrow function, and decreased lung function, and have very low regenerative capacity in certain tissues. This is clinical evidence showing how widely the telomere management system is needed in various tissues of the human body.

From an evolutionary perspective, telomeres and telomerase are early inventions of eukaryotes. Since the evolution of linear chromosomes, this system has been necessary, and protozoa, yeast, plants, and animals all use similar telomere repeat sequences and telomerase enzymes. The fact that this architecture, which solves the fundamental problem of information loss with buffer sequences and initialization subroutines, has not fundamentally changed for billions of years speaks to the robustness of this design.

The symbolism of the two women together on the podium must also be recorded. The story of this collaboration between Professor Blackburn and graduate student Greider is often cited as one of the ideal models for the advancement of women in science, collaborative mentoring relationships, and intergenerational knowledge transfer. The fact that the ninth Nobel Prize in Physiology or Medicine of the new century opened with such a story was also a moment to celebrate the cultural changes in the 21st-century scientific community.

A single repeat sequence at the end of the chromosome has become a window to understanding the aging and youth of cells, cancer and regeneration, and the quiet calculations that take place daily in many tissues of our body. Cells are not infinite, and we now know where the clock of their finitude is.

→ Previous: 2008 Nobel Prize in Physiology or Medicine → Next: 2010 Nobel Prize in Physiology or Medicine